Recruiting Fibromyalgia Studies in Louisville
Study of Selinexor in Combination with Ruxolitinib in Myelofibrosis
This is a global, multicenter, 2-part study to evaluate the efficacy and safety of selinexor plus ruxolitinib in JAK inhibitor (JAKi) treatment-naïve myelofibrosis (MF) participants. The study will be...
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF....
About Fibromyalgia Clinical Trials in Louisville
Fibromyalgia is a condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties. It affects about 2-4% of the population, predominantly women. Treatment includes medications, exercise, stress management, and cognitive behavioral therapy.
There are currently 2 fibromyalgia clinical trials recruiting participants in Louisville, KENTUCKY. These studies are seeking a combined 478 participants. Research is being sponsored by Karyopharm Therapeutics Inc, Cumberland Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fibromyalgia Clinical Trials in Louisville — FAQ
Are there fibromyalgia clinical trials in Louisville?
Yes, there are 2 fibromyalgia clinical trials currently recruiting in Louisville, KENTUCKY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Louisville?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Louisville research site will contact you about next steps.
Are clinical trials in Louisville free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Louisville studies also compensate for your time and travel.
What fibromyalgia treatments are being tested?
The 2 active trials in Louisville are testing new therapies including novel drugs, biologics, and treatment approaches for fibromyalgia.
Data updated March 2, 2026 from ClinicalTrials.gov